Skip to main content

ORTHOFIX International N V Value Stock - Dividend - Research Selection

Orthofix international n v

ISIN: US68752M1080 , WKN: A2NB0X

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Orthofix International N.V., a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. Orthofix International N.V. was founded in 1987 and is headquartered in Lewisville, Texas.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Orthofix Medical Inc.'s (NASDAQ:OFIX) Intrinsic Value Is Potentially 74% Above Its Share Price

2025-09-17
Key Insights Orthofix Medical's estimated fair value is US$25.87 based on 2 Stage Free Cash Flow to Equity Current...

Do You Believe in the Growth Potential of Orthofix Medical (OFIX)?

2025-09-15
Rewey Asset Management, an investment management company, released its “RAM Smid Composite” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The composite increased 6.11% in Q2 2025, slightly trailing a 7.29% gain for the benchmark Russell 2500 Value Total Return Index. Year-to-date, the composite returned -1.29% vs. 1.03% for […]

Orthofix Medical: Spending, Not Producing Additional Income

2025-09-09
Orthofix's SeaSpine acquisition has yet to deliver economic value, with ROIC still far below acceptable equity hurdle rates. See why OFIX stock is a Hold.

Barrington Lifts PT on Orthofix Medical (OFIX) to $17 From $16, Keeps an Overweight Rating

2025-08-13
Orthofix Medical Inc. (NASDAQ:OFIX) is one of the best medical device stocks to buy according to analysts. Barrington analyst Michael Petusky raised the firm’s price target on Orthofix Medical Inc. (NASDAQ:OFIX) to $17 from $16 on August 6, keeping an Outperform rating on the shares. The analyst told investors in a research note that Orthofix Medical […]

3 Top Undervalued Small Caps With Insider Buying In Various Regions

2025-08-07
As the U.S. stock market navigates a complex landscape of earnings reports and tariff developments, small-cap stocks within the S&P 600 have become a focal point for investors seeking opportunities amid broader economic uncertainties. With insider buying often seen as a positive indicator of confidence in a company's prospects, identifying undervalued small caps can be particularly appealing in today's market environment.

Orthofix Medical: Compelling Valuation Supported By Insider Purchases

2025-08-06

Orthofix Medical Second Quarter 2025 Earnings: Beats Expectations

2025-08-06
Orthofix Medical ( NASDAQ:OFIX ) Second Quarter 2025 Results Key Financial Results Revenue: US$203.1m (up 2.3% from 2Q...

Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates

2025-08-05
Orthofix (OFIX) delivered earnings and revenue surprises of +225.00% and +3.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Orthofix: Q2 Earnings Snapshot

2025-08-05
LEWISVILLE, Texas (AP) — Orthofix Medical Inc. OFIX) on Tuesday reported a loss of $14.1 million in its second quarter. The Lewisville, Texas-based company said it had a loss of 36 cents per share.

Orthofix Medical Inc. 2025 Q2 - Results - Earnings Call Presentation

2025-08-05
The following slide deck was published by Orthofix Medical Inc.